Date: 13 March 2019
The paediatric research team at University Hospital Southampton NHS Foundation Trust have recruited the first UK patient into an early phase study exploring the dose and safety of a new antibiotic for children and young infants.
Saul Faust, professor of paediatric immunology and infectious diseases said: “It’s fantastic that parents feel able to take part in such early stage trials of new antibiotics in very young babies – this is really important if we are going to be able to fight bacteria that are resistant to commonly used antibiotics using the right doses for each age group."
Professor Faust, who is also the director of the NIHR Southampton Clinical Research Facility (CRF) added: "This study is possible because of the joint support provided by the NIHR Southampton CRF and NIHR CRN Wessex, as well as the sponsor (Merck) who were really happy to work with the UK clinical research teams to make the study do-able in the NHS.”
You may also be interested in